1 / 12

Siegfried at a glance

Siegfried at a glance. Overview. Commitment of some 850 employees First choice in compliance, responsiveness and reliability Over 130 years of continuity, global presence Process Development experience from over 1,600 substances, extensive services. Overview. Our Vision.

jagger
Download Presentation

Siegfried at a glance

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Siegfried at a glance

  2. Overview • Commitment of some 850 employees • First choice in compliance, responsiveness and reliability • Over 130 years of continuity, global presence • Process Development experience from over 1,600 substances, extensive services

  3. Overview Our Vision Expect more with Siegfried as your preferred partner Bringing together our long-standing pharma and chemical heritage, we offer as an integrated partner benefit to our customers with more synergy, expertise and value. Explore more about how our broad range of custom development services, drug substance & drug product manufacturing capabilities, together with our existing product portfolio may help you achieve greater value.

  4. Overview Locations

  5. Overview Past do Present 1873 Pharmacist Samuel Benoni Siegfried founds a company with 12 employees as a supplier to pharmacies 1904 Conversion into a joint stock corporation 1937 Founding of Ganes Chemical Works, Inc. (NJ, USA) 1973 Quotation on the Swiss Stock Exchange (SWX) in Basel 1991 Focus on development and custom manufacturing 2001 Building of two core divisions: Siegfried and Sidroga

  6. Overview Past to Present • Integration of Ganes into the Siegfried Group = Siegfried (USA) Inc. 2005 Acquisition of Penick Corporation in New Jersey, USA • Launch of a new pharmaceutical production facility in Malta Sale of the Sidroga Division Sale of the biotech activities • Sale of the pharmaceutical production site Zofingen • Definition of new strategy «Transform»Implementation of a new function- based organisation. New investors and capital increase. Sale of Munich, Germany subsidiary (Pulmojet project) to Sanofi-Aventis.

  7. Strategy Position

  8. Products & Services Two Strong Business Areas Business Area Drug Substances Custom synthesis of APIs and intermediates, as well as production of standard substances, particularly controlles substances for analgesics and narcotics. Drug Products Process development and production of complex drug products and finished dosage forms. Products & Services

  9. ManagementBoard of Directors Felix Meyer Gilbert AchermannChairman Thomas Villiger. Andreas Casutt Reto Garzetti Reto Garzetti

  10. ManagementExecutive Committee Rudolf HankoChief Executive Officer Marianne SpäneHead Business Development & Sales Arnoud MiddelHead Human Resources Peter GehlerHead Corporate CenterSecretary to the Board of Directors Walter KittlHead Technical Operations Wolfgang Wienand.Chief Scientific Officer, Head of Strategy and M & A René Imwinkelried Head Research & Development Michael HüslerChief Financial Officer

  11. Human Resources Vision • Socially responsible employer • Motivated and talented personnel • Mutual respect • Personal responsibility • Focusing on results

  12. Thank you for your attention

More Related